Financial Daily from THE HINDU group of publications
Sunday, Apr 20, 2003

News
Features
Stocks
Port Info
Archives

Group Sites

Marketing - New Products & Services


Aurobindo joint venture launches new product

Our Bureau

HYDERABAD, April 19

PHARMACEUTICAL major Aurobindo Pharma Ltd (APL), has announced here that its joint venture with Citadel - Citadel Aurobindo Bitoech Ltd - has launched a new product — Aztreonam, a monobactam betalactum antibiotic, for the first time in the Indian pharmaceutical market.

Branded as `Treonam', the drug is claimed to be highly useful for the treatment of infections due to gram negative aerobes including pseudomonas aeruginosa, a highly difficult to treat pathogen.

According to Aurobindo Pharma, the drug is a useful antibiotic in hospital and ICU setting for infections such as pyelonephritis, septicaemia, pneumonia, post-operative wounds and burns, intra-abdominal infections, gynaecological infections and surgery.

Article E-Mail :: Comment :: Syndication

Stories in this Section
Aurobindo joint venture launches new product




The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |

Copyright © 2003, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line